Morteza Aghmesheh - Concepedia

Author

Morteza Aghmesheh

Also Known As

Aghmesheh Morteza, Aghmesheh, Morteza, Ayesha Saqib, Bruna Angelelli, David J. Hunter, Eric Wang, M. AGHMESHEH, M. Aghmesheh, Morteza Aghmesheh, Xiaoqing Chen

105

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

Wollongong Hospital University of Wollongong Illawarra Health and Medical Research Institute Ingham Institute The University of Sydney

About

Morteza Aghmesheh is an author at Wollongong Hospital specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2.5K
2	Health Sciences	6	6	621
3	Engineering	2	2	48
4	Applied Physiology	2	2	32
5	Biomedical Engineering	1	1	27

Morteza Aghmesheh

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau, The Lancet MedicinePathologyHead And Neck CancerCancer TreatmentNeck Oncology	2018	1.6K
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial Sun Young Rha, Do‐Youn Oh, Patricio Yañez, The Lancet Oncology Chemotherapy Versus PlaceboGastrointestinal OncologyMedicineClinical TrialsImmune Checkpoint Inhibitor	2023	521
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial Peter Grimison, Antony Mersiades, Adrienne Kirby, Annals of Oncology Cannabis UsePsychoactive DrugOral ThcPharmacologyNeuropharmacology	2020	143
Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin Ulrich‐Axel Bommer, Kara L. Vine, Prianka Puri, Cell Communication and Signaling	2017	50
Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer Daniel Brungs, Elahe Minaei, Ann‐Katrin Piper, Scientific Reports	2020	47
Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer Daniel Brungs, Morteza Aghmesheh, Paul de Souza, Clinical Colorectal Cancer OncologyElderly PatientsGastrointestinal OncologyColorectal CancerPathology	2018	45
Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors? Morteza Aghmesheh, J. M. Nesland, Haavard E Danielsen, International Journal of Gynecological Cancer	2005	43
Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients Daniel Brungs, Morteza Aghmesheh, Paul de Souza, BMC Cancer	2017	42
Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study. Jeanne Tie, Joshua D. Cohen, Yuxuan Wang, Journal of Clinical Oncology Surgical OncologyTumor Dna AnalysisColorectal SurgeryCancer ManagementAdjuvant Chemotherapy	2024	34
Preparation and in vitro assessment of wet-spun gemcitabine-loaded polymeric fibers: Towards localized drug delivery for the treatment of pancreatic cancer Samantha J. Wade, Zuzic Amanda, Javad Foroughi, Pancreatology Cell-based Drug DeliveryNanomedicineEngineeringPancreatic CancerPolymer-drug Conjugate	2017	27

Page 1